Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras.

ABSTRACT: Many diseases, including cancer, stem from aberrant activation or overexpression of oncoproteins that are associated with multiple signaling pathways. Although proteins with catalytic activity can be successfully drugged, the majority of other protein families, such as transcription factors, remain intractable due to their lack of ligandable sites. In this study, we report the development of TRAnscription Factor TArgeting Chimeras (TRAFTACs) as a generalizable strategy for targeted transcription factor degradation. We show that TRAFTACs, which consist of a chimeric oligonucleotide that simultaneously binds to the transcription factor of interest (TOI) and to HaloTag-fused dCas9 protein, can induce degradation of the former via the proteasomal pathway. Application of TRAFTACs to two oncogen

SUBMITTER: Samarasinghe KTG 

PROVIDER: S-EPMC8524358 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature